The effect of alpha-lipoic acid (ALA) on women with episodic migraines was recently published in the Nature Research journal Scientific Reports. In this randomized and double-blinded trial, 92 women between the ages of 20-50 with episodic migraines (< 15 headache days per month) received either 300 mg ALA twice per day or a matching placebo…